THI awarded with regular license by Sindh Healthcare Commission pakobserver.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pakobserver.net Daily Mail and Mail on Sunday newspapers.
Tabba Heart Institute jobs 2021 in Pakistan. Latest THI jobs ads in newspapers on PaperAds.com . Apply for latest Tabba Heart Institute Karachi jobs though advertisement of THI careers and get hired. We update all new Tabba Heart Institute jobs from Roznama Jang, Express , Nation and Dawn newspapers daily.
“Heart disease is the world’s number one killer and is responsible for 19 million premature deaths and results in 31 per cent of all global deaths. The incidence of heart diseases is steadily.
Study under way to assess risk of Atherosclerotic Cardiovascular Disease in Pakistan
Karachi
May 2, 2021
One-fourth or 25 per cent of the South Asian Countries’ population is at an increased risk of developing Atherosclerotic Cardiovascular Disease (ASCVD), experts said recently, warning that prevalence of the disease continues to rise in South Asian countries, including Pakistan where ASCVD remains the leading cause of death.
Although Pakistan is the second most populous country in South Asia, most of the data on the prevalence of cardiovascular diseases from the South Asian region is derived from India, they said, adding that as a result, the Pakistani population is highly underrepresented in global research as there is currently no comprehensive database on the native Pakistani population to assess the likelihood of developing ASCVD.
Getz Pharma Enters Into A Joint Venture With Tabba Heart
Getz Pharma and Tabba Heart Institute, to address the issue of the rising health burden of ASCVD in Pakistan, are entering into a Joint Venture Agreement for the largest, first-of-its-kind, longitudinal cohort study on Atherosclerotic Risk Assessment in Pakistani Population.
This study aims to recruit healthy volunteers aged 30 years or older from selected urban and rural areas of Pakistan who are asymptomatic and have no cardiovascular disease. This would allow for assessing the participants’ risk factor profiles and follow them up for at least ten years to document the incidence of ASCVD.